Page last updated: 2024-08-22

angiotensin ii and 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one

angiotensin ii has been researched along with 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, WQ; Cui, GH; Shen, ZY	1

Other Studies

1 other study(ies) available for angiotensin ii and 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one

Article	Year
Urolithin A shows anti-atherosclerotic activity via activation of class B scavenger receptor and activation of Nef2 signaling pathway. Pharmacological reports : PR, 2018, Volume: 70, Issue:3 Topics: Angiotensin II; Animals; Aorta; Atherosclerosis; CD36 Antigens; Coumarins; Hypercholesterolemia; Lipids; Male; MAP Kinase Signaling System; NF-E2-Related Factor 2; Rats; Rats, Wistar; Receptors, Scavenger; Signal Transduction; Up-Regulation	2018

Article

Year

Urolithin A shows anti-atherosclerotic activity via activation of class B scavenger receptor and activation of Nef2 signaling pathway.

Pharmacological reports : PR, 2018, Volume: 70, Issue:3

Topics: Angiotensin II; Animals; Aorta; Atherosclerosis; CD36 Antigens; Coumarins; Hypercholesterolemia; Lipids; Male; MAP Kinase Signaling System; NF-E2-Related Factor 2; Rats; Rats, Wistar; Receptors, Scavenger; Signal Transduction; Up-Regulation

2018